Evidence map›Paper›PMID 33063223›Full record

ArticleInternational journal of colorectal disease2021

Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.

Estefania Flores, Chimezie Mbachi, Ikechukwu Achebe, Jennifer Asotibe, Emmanuel Palomera-Tejeda, Ishaan Vohra, Victor Udechukwu, Vikram Kotwal

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Estefania FloresDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA. estefaniaflorescordova@gmail.com.ORCID http://orcid.org/0000-0002-8583-6020
Chimezie MbachiGastroenterology and Hepatology, Yale School of Medicine, New Haven, CT, USA.
Ikechukwu AchebeDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA.
Jennifer AsotibeDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA.
Emmanuel Palomera-TejedaDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA.
Ishaan VohraDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA.
Victor UdechukwuDepartment of Medicine, Cook County Health and Hospitals System, Chicago, IL, USA.
Vikram KotwalDivision of Gastroenterology and Hepatology, Cook County Health and Hospitals System, County, Chicago, IL, USA.
Cook County Health and Hospitals System · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly detection and advancement in therapy have successfully achieved a steady decrease in colorectal cancer (CRC) mortality over the last two decades. On the other hand, studies investigating mortality trends in inflammatory bowel disease-associated CRC (IBD-CRC) are scarce and inconclusive. We conducted a retrospective analysis aiming to identify differences between inpatient mortality trends in IBD-CRC vs non-IBD-CRC and possible contributing factors.

methodsThe National Inpatient Sample (NIS) database from 2006-2014 was queried to identify all patients admitted with a diagnosis of CRC. The main outcome was the prevalence and trend of mortality among IBD-CRC and non-IBD-CRC. The secondary outcome was the evaluation of predictors of inpatient mortality.

resultsA total of 1,190,759 weighted cases with the admission diagnosis of CRC were included in the study. Of which 10,997 (0.9%) had a co-diagnosis of IBD. The population with non-IBD-CRC had a statistically significant downward temporal trend in mortality (p < 0.001), while patients with IBD-CRC did not have any statistically significant temporal trend in inpatient mortality (p = 0.067). After subgroup analysis, patients with Crohn's disease-CRC had an upward temporal trend in mortality (p = 0.183) compared to patients with ulcerative colitis-CRC with a downward trend in mortality (p = 0.001). Sepsis resulted to be a stronger predictor of mortality for CD-CRC, while VTE for UC-CRC.

conclusionMultiples strategies established to prevent morbidity and mortality in CRC have been fruitful in non-IBD-CRC population, but have not been enough for IBD-CRC population to cause the same effect. Further strategies are needed to achieve a reduction in IBD-CRC mortality trend.

Indexed as

Colitis, UlcerativeColorectal NeoplasmsInflammatory Bowel DiseasesHumansInpatientsRetrospective StudiesRisk FactorsCrohn’s disease-associated colorectal cancerInflammatory bowel disease-associated colorectal cancerMortality in inflammatory bowel diseaseUlcerative colitis-associated colorectal cancer

Identifiers

PMID33063223
OpenAlexW3093347411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.